info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Amblyopia Market Research Report Information By Type (Strabismus amblyopia, Refractive amblyopia, Deprivation amblyopia, and Reverse amblyopia), By Diagnosis (Visual acuity tests, Photo screening, Bruckner test, and Others), By Treatment (Eye patches, Atropine drops, Glasses, Video game, and Others), By End-Users (Hospitals & pharmacies, and Ophthalmic clinics), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032


ID: MRFR/MED/2967-HCR | 108 Pages | Author: Rahul Gotadki| December 2024

Global Amblyopia Market Overview


Amblyopia Market Size was valued at USD 4.5 billion in 2021 and is projected to grow from USD 4.68 Billion in 2022 to USD 6.4 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.3% during the forecast period (2023 - 2032). Increasing cases of ophthalmological disorders including refractive errors and cataracts and government funding for ophthalmology research are the key market drivers enhancing the market growth.Amblyopia Market


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Amblyopia Market Trends



  • Rising Incidence of Amblyopia to boost market growth


Amblyopia is very common in childhood, with a worldwide incidence ranging from 0.2% to 6.2%. According to the journal published in Karger International, the article estimated that 99.2 million people had low vision in 2019, 175.2 million by 2030, and 221.9 million by 2040. This may help in boosting demand of the market.


Several major market players are focused on launching technologically advanced products to treat amblyopia. This is anticipated to boost the amblyopia treatment market during the forecast period. For example, in March 2021, NovaSight received 510(k) clearance from the Food and Drug Administration for CureSight to treat amblyopia. The device helps train the brain to use both eyes simultaneously while the user watches videos through her 3D glasses.


Video games are fast becoming an innovative treatment option for amblyopia. Investors in the amblyopia treatment market are raising awareness of the proper use of video games in young children by improving the brain-eye connection. It has been shown that eye patches may not help the eyes learn to work together. Various companies in the amblyopia treatment market are increasingly focusing on video games to get children and parents on board quickly. However, Lack of skilled professionals and high cost related to its treatment factors restraining the growth of the Amblyopia market revenue.


Amblyopia Market Segment Insights


Amblyopia Type Insights


The Amblyopia market segmentation, based on type, includes Strabismus amblyopia, Refractive amblyopia, Deprivation amblyopia, and Reverse amblyopia. The Strabismus amblyopia segment held the majority share in 2021 in respect to the Amblyopia market revenue. This is primarily owing to the rising numbers of patients suffering from strabismic amblyopia across the globe. Strabismus is the most common cause of amblyopia. Refractive amblyopia was the second largest segment in terms of market share in 2021. The increase in the prevalence of refractive amblyopia is anticipated to drive the segment during the forecast period. According to the American Academy of Ophthalmology, the prevalence of anisometropic amblyopia is about 4.7% in children.


Amblyopia Diagnosis Insights


The Amblyopia market segmentation, based on Diagnosis, includes Visual acuity tests, Photo screening, Bruckner test, and others. The visual acuity tests segment dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2022-2030. It is basic and mandatory test required before the amblyopia treatment. Further, Increasing research & development and continuous improvements in the Brückner test is fueling the growth of this segment in the amblyopia market. Hence, rising applications of visual acuity tests for Amblyopia positively impacts the market growth.


Amblyopia Treatment Insights


The Amblyopia market data has been bifurcated by Treatment into Eye patches, Atropine drops, Glasses, Video game, and Others. The eye patch segment dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2022-2030. This is due to the wearing an eye patch is a simple, cost-effective treatment for lazy eye and it also helps improve vision in the weaker eye. Further, the launch of new eye patches for the treatment of amblyopia is driving demand in this segment. Also, video games are emerging as an innovative treatment options.


March 2021 Novasight received the food and drug administration clearance for CureSight for the treatment of amblyopia. The device trains the brain to use both eyes simultaneously, while the user watches videos through 3D glasses. This initiative has further broadened the growth opportunity for the Amblyopia industry.


In addition, Companies in the amblyopia treatment market are seeing high demand for pure cotton amblyopia eye patches for eyewear to treat children suffering from strabismus amblyopia. To do so, it focus on developing advanced, reusable, pure cotton eye patches for amblyopia. It also develop innovative designs with cartoons in products to attract children.


Figure 2 Amblyopia Market, by Treatment, 2021 & 2030 (USD Billion)Amblyopia Market, by Treatment, 2021 & 2030


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Amblyopia End User Insights


Based on End Users, the Amblyopia industry has been segmented into Hospitals & pharmacies, and Ophthalmic clinics. Hospitals & pharmacies held the largest segment share in 2021, owing to the easy availability of treatment facilities. Moreover, the proximity to the skills and awareness of hospitals and pharmacies among end-users underpins a large share of the market.


In addition, the segment of ophthalmology clinics is witnessing a growing consumer awareness of these centers therefore it is expected to grow significantly. Additionally, the company's increasing focus on opening new eye clinics is boosting the growth of the low vision market. New and emerging players are facing competition in the low vision market with an eye on this segment..


Amblyopia Regional Insights


By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. Asia-Pacific Amblyopia market accounted for USD 1.899 billion in 2021 and is expected to exhibit a significant CAGR growth during the study period. The region constituted 42.20% share of the market in 2021. This is attributed to the increasing availability of amblyopia treatment technologies across the region. Moreover, increasing penetration of new companies, through mergers and acquisitions, fuels the market in the region.


Further, the major countries studied in the market report are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 3 AMBLYOPIA MARKET SHARE BY REGION 2021 (%)AMBLYOPIA MARKET SHARE BY REGION 2021


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Europe Amblyopia market accounts for one of the largest market share due to the availability of cutting-edge treatment facilities, government backing for the growth of the healthcare industry, Increase in number of amblyopia cases in Europe is driving the growth of the market in the region. Moreover, High purchasing power among consumers in the region positively influences the growth of the market. Further, the Germany Amblyopia market held the largest market share, and the UK Amblyopia market was the fastest growing market in the European region


The North America Amblyopia Market is expected to grow at the fastest CAGR from 2022 to 2030. This is due to the presence of advanced technologies in the medical industry. Moreover, easy availability of recourses supports the growth of key players and new entrance in the market in this region. Moreover, China Amblyopia market held the largest market share, and the India Amblyopia market was the fastest growing market in the Asia-Pacific region.


Amblyopia Key Market Players & Competitive Insights


Major market players are spending a lot of money on R&D to increase their product lines, which will help the Amblyopia market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the Amblyopia industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.


One of the primary business strategies adopted by manufacturers in the Amblyopia industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, Amblyopia industry has provided medicine with some of the most significant benefits. The Amblyopia market major player such as Amblyotech, Good-Lite Co., Vivid Vision, Cooper Vision, Johnson & Johnson, Novartis AG, Carl Zeiss, HOYA Corporation, Hilco Vision., and others are working to expand the market demand by investing in research and development activities.


CooperVision, Inc. is a business unit of The Cooper Companies, Inc. It is a soft contact lens manufacturer headquartered in Pleasanton, U.S. The company reorganized into Cooper Laboratories, Cooper Medical Devices, Cooper Dental, Cooper International, and CooperVision. CooperVision offers scientific and technological innovation, operational excellence and close working relationships with eye care professional and customers. In 2019, CooperVision, Inc., acquired Blanchard Contact Lenses, Inc., which helped the company to expand its presence in the specialty segment. This creates more opportunities for CooperVision to partner with eye care professionals, and for them to meet a range of patient needs.


Also, Novartis AG use innovative science and technology to address some of society's most challenging healthcare issues. It develop treatments and innovative ways to deliver to peoples. Its projects includes new molecular entities as well as additional indications and different formulations for marketed products, are for medicines that could significantly advance treatment standards for patients ly. In 2019, Novartis AG acquired Takeda eye drug for approximately US$ 5.3 Bn, which helped the company to expand its product portfolio.


Key Companies in the Amblyopia market includes



  • Amblyopia (Holding) Pty Ltd

  • Amblyotech Inc

  • Good-Lite Co

  • Vivid Vision Inc.

  • Cooper Vision

  • Johnson & Johnson

  • Novartis AG

  • Carl Zeiss AG

  • HOYA Corporation

  • Krafty Eye Patches


Amblyopia Industry Developments


In October 2021 HOYA Vision Care, announced a partnership with Orbis International, which is a  organization that mentors, trains, and inspires local eye care professionals to save sight in their communities. The main aim behind this strategic partnership is to bridge the vision care gap around the world.


April 2020 Novartis announced the complete acquisition of the USA-based software start-up Amblyotech Inc. and will work with Ubisoft and McGill University to develop the acquired digital technology for the treatment of amblyopia. Amblyotech is a clinical-stage digital therapeutics company involved in the treatment and diagnosis of amblyopia and other several eye-related disorders.


Amblyopia Market Segmentation


Amblyopia Type Outlook



  • Strabismus amblyopia

  • Refractive amblyopia

  • Deprivation amblyopia

  • Reverse amblyopia


Amblyopia Diagnosis Outlook



  • Visual acuity tests

  • Photo screening

  • Bruckner test

  • Others


Amblyopia Treatment Outlook



  • Eye patches

  • Atropine drops

  • Glasses

  • Video game

  • Others


Amblyopia End-User Outlook



  • Hospitals & pharmacies

  • Ophthalmic clinics


Amblyopia Regional Outlook




  • North America

    • US

    • Canada




  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe




  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific




  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Report Attribute/Metric Details
Market Size 2021 USD 4.50 billion
Market Size 2022 USD 4.68 billion
Market Size 2032 USD 6.4 billion
Compound Annual Growth Rate (CAGR) 4.3% (2023-2032)
Base Year 2021
Market Forecast Period 2023-2032
Historical Data 2018 & 2020
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Type, Diagnosis, Treatment, End User, and Region
Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled Amblyotech, Good-Lite Co., Vivid Vision, Cooper Vision, Johnson & Johnson, Novartis AG, Carl Zeiss, HOYA Corporation, Hilco Vision., and others
Key Market Opportunities Supportive government initiatives for electric vehicles
Key Market Dynamics Rising demand for vehicles in developing economies Growing awareness regarding automotive HUD among consumers


Frequently Asked Questions (FAQ) :

The Amblyopia market size was valued at USD 4.50 Billion in 2021.

The market is projected to grow at a CAGR of 4.3% during the forecast period, 2023-2032.

Asia-Pacific had the largest share in the market

The key players in the market are Amblyotech, Good-Lite Co., Vivid Vision, Cooper Vision, Johnson & Johnson, Novartis AG, Carl Zeiss, HOYA Corporation, Hilco Vision., and others.

The Strabismus amblyopia type dominated the market in 2021.

The visual acuity tests diagnosis had the largest share in the market.

Leading companies partner with us for data-driven Insights.

client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.